PSMA-Directed CAR T Cells Combined with Low-Dose Docetaxel Treatment Induce Tumor Regression in a Prostate Cancer Xenograft Model
Download full text files
Additional Services
Statistics
| Author: | Jamal Alzubi, Viviane Dettmer-Monaco, Johannes Kuehle, Niko Thorausch, Maximilian Seidl, Sanaz TaromiORCiD, Wolfgang Schamel, Robert Zeiser, Hinrich Abken, Toni Cathomen, Philipp Wolf |
|---|---|
| URN: | https://urn:nbn:de:bsz:fn1-opus4-75799 |
| DOI: | https://doi.org/10.1016/j.omto.2020.06.014 |
| ISSN: | 2372-7705 |
| Parent Title (English): | Molecular Therapy Oncolytics |
| Document Type: | Article (peer-reviewed) |
| Language: | English |
| Year of Completion: | 2020 |
| Release Date: | 2021/10/26 |
| Tag: | CAR T cells; Chemotherapy; Docetaxel; Focal therapy; Prostate cancer |
| Volume: | 18.2020 |
| Issue: | September |
| First Page: | 226 |
| Last Page: | 235 |
| Open-Access-Status: | Open Access |
| Licence (German): |  Creative Commons - CC BY-NC-ND - Namensnennung - Nicht kommerziell - Keine Bearbeitungen 4.0 International |